1-877-439-2744 Motherisk Helpline
1-800-436-8477 Morning Sickness
1-877-327-4636 Alcohol and Substance
1-866-937-7678 Exercise in Pregnancy
1-888-246-5840 HIV and HIV Treatment
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
- Read more in our News Archive
Current Studies at Motherisk
The Safety of Diclectin in Breastfeeding
Neurodevelopment of Children Exposed in-Utero to Chemotherapy for Maternal Breast Cancer (Dr. I Nulman)
Diclegis Surveillance Program Study
Diclectin Surveillance Program Study
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
Pregnancy in Women with Multiple Sclerosis
Alcohol Use during Pregnancy
Autoimmune Diseases in Pregnancy Project
Preventing fetal alcohol spectrum disorders. Preconception counseling and diagnosis help
Suzanne C. Tough, PHD Margaret Clarke, MD Sterling Clarren, MD
By the time women find out they are pregnant and see a family physician, they might have already consumed alcohol during the pregnancy and affected the development of their fetuses. How can family physicians better prevent exposure to alcohol during pregnancy?
Women of childbearing age should be counseled about the risks associated with alcohol consumption during pregnancy before they become pregnant. Diagnosing children who have fetal alcohol spectrum disorders can help identify birth mothers who are at risk of other alcohol-exposed pregnancies and who need support to change their behaviour.
Avant que les femmes apprennent qu'elles sont enceintes et qu'elles voient leur médecin de famille, elles peuvent avoir déjà consommé de l'alcool durant leur grossesse et affecté le développement de leur foetus. Comment les médecins de famille peuvent-ils mieux prévenir l'exposition à l'alcool durant la grossesse?
Les femmes en âge de procréer devraient recevoir des conseils sur les risques associés à la consommation d'alcool durant la grossesse avant qu'elles deviennent enceintes. Le diagnostic d'enfants souffrant de troubles reliés à l'alcoolisme foetal peut aider à identifier les mères naturelles qui sont à risque de vivre d'autres grossesses où le foetus sera exposé à l'alcool et qui ont besoin de soutien pour modifier leur comportement.
Fetal alcohol spectrum disorder (FASD) is the most common preventable cause of mental disability in the western world with an estimated incidence in North America of 9.1 per 1000 live births.1,2 Fetal alcohol spectrum disorder refers to a group of conditions that can include abnormalities in facial features, growth deficiency, and central nervous system dysfunction in children whose mothers consumed alcohol during pregnancy. Children with all these characteristics are described as having fetal alcohol syndrome. In Canada, estimated lifetime costs for one person with FASD for additional education, disability payments, and health care are $844 066.3 Studies of alcohol-consumption trends in pregnant women and women of childbearing age and a recent Canadian survey of the attitudes and approaches of health care providers to FASD highlight opportunities for prevention.4-7
Prevention through preconception counseling
Women can negatively affect the development of their fetuses before they even realize they are pregnant by consuming alcohol after conception. Thus, women of childbearing age should be made aware of the risks of alcohol consumption during pregnancy before they become pregnant. Less than half of the family physicians in one study frequently discussed the risks of alcohol use, drug use, or smoking during pregnancy with women of childbearing age (ie, before conception).6 Since most family physicians (85%) discussed birth control with these women, they could also discuss other aspects of reproductive health, including the way behaviour can affect pregnancy and birth outcomes.6 They can use discussions about birth control and sexual activity to ensure women are aware that alcohol and drug use and smoking during pregnancy can affect the development of their babies? physical and central nervous systems and increase the risk of lifelong disabilities.8,9 Women should also be made aware that very early pregnancy is a particularly critical time for fetal development.10
In assessing risk of alcohol exposure during pregnancy, family physicians should obtain a detailed history of alcohol and drug use and of sexual and emotional abuse, as well as a family history of addictions, all of which are important determinants of alcohol abuse.11 These questions will help physicians probe for information about current alcohol use and allow them to define low-risk drinking for non-pregnant women. When physicians identify women who are consuming too much alcohol (ie, more than two drinks per occasion or more than nine standard drinks per week),12 they can take action to prevent future alcohol-exposed pregnancies by discussing the risks of alcohol consumption during pregnancy and by referring women to resources where necessary.
Prevention through diagnosis of FASD
Another approach to prevention is through diagnosis of FASD. Children with FASD have birth mothers who could be at risk of having other children with FASD.13 Awareness of the diagnostic criteria for FASD will help physicians identify both children with FASD and mothers at risk of alcohol consumption during pregnancy. Women at risk could be referred to resources that support lifestyle change to prevent future alcohol-exposed pregnancies.
In one study, almost 70% of family physicians identified a need for additional training in diagnosis of FASD.5 Although 94% of family physicians in the study agreed that fetal alcohol syndrome was identifiable, and 77% agreed that making a diagnosis of fetal alcohol syndrome was within their scope of practice, only about 60% were aware that a combination of growth, brain, and facial abnormalities provide the most accurate diagnosis of fetal alcohol syndrome.5 The release of Canadian guidelines for diagnosing FASD could help family physicians identify children with the diagnostic features of FASD.14 If children under their care have such features, these children should be referred to multidisciplinary diagnostic teams, where possible, for more comprehensive diagnostic examination.
According to the guidelines, children should be referred for diagnosis if family physicians observe:
- the three characteristic facial features: short palpebral fissures, a smooth or flattened philtrum, and a thin vermilion border; or
- any of the characteristic facial features plus prenatal or postnatal growth deficits, or central nervous system deficits plus known or probable substantial prenatal exposure to alcohol. 14
Family physicians should also be aware of the secondary outcomes associated with FASD, including long-term emotional disorders, disrupted schooling, addictions, legal problems, and inappropriate sexual behaviour. A better understanding of secondary disabilities might prompt family physicians to inquire about prenatal alcohol exposure in cases where a diagnosis of FASD was missed in infancy.
Identifying a missed diagnosis of FASD presents an opportunity to prevent future alcohol-exposed pregnancies because about one third of those with FASD experience drug and alcohol problems during their lives.15 Affected women can be referred to resources that can help them develop and maintain a healthy lifestyle, thus preventing FASD.
Greater efforts at preventing FASD, including preconception counseling, improved diagnosis of children with FASD, and identification of patients at risk, could reduce the incidence of FASD. These efforts require the support and involvement of family physicians who need to routinely and thoroughly assess alcohol use and risky behaviour among women of childbearing age, particularly among those who might become pregnant.
When women become pregnant, they should be screened at the first prenatal visit using a standard screening tool, such as the T-ACE (tolerance, annoyed, cut down, eye-opener).16 A screening tool paired with a discussion about alcohol consumption might assist family physicians in determining whether women were drinking heavily at any time during pregnancy and whether there is risk of continued alcohol consumption.
- Clarren SK, Smith DW. The fetal alcohol syndrome. N Engl J Med 1978;298(19):1063-7.
- Sampson PD, Streissguth AP, Bookstein FL, Little RE, Clarren SK, Dehaene P, et al. Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorder. Teratology 1997;56(5):317-26.
- Stade B. The burden of prenatal exposure to alcohol: quality of life and costs [dissertation]. Toronto, Ont: University of Toronto; 2003.
- Tough SC, Clarke M, Hicks M, Clarren SK. Clinical practice characteristics and preconception counseling strategies of health care providers who recommend alcohol abstinence during pregnancy. Alcohol Clin Exp Res 2004;28(11):1724-31.
- Clarke M, Tough SC, Hicks M, Clarren SK. Approaches of Canadian providers to the diagnosis of fetal alcohol spectrum disorders. J FAS Int 2005;3:e2. Available from: http://www.motherisk.org/JFAS/. Accessed 2005 July 21.
- Tough SC, Clarke ME, Hicks M, Clarren SK. Attitudes and approaches of Canadian providers to preconception counselling and the prevention of fetal alcohol spectrum disorders. J FAS Int 2005;3:e3. Available from: www.motherisk.org/JFAS. Accessed 2005 July 21.
- Centers for Disease Control and Prevention. Alcohol use among women of childbearing age?United States, 1991-1999. MMWRMorb Mortal Wkly Rep 2002;51(13):273-6.
- Horta BL, Victora CG, Menezes AM, Halpern R, Barros FC. Low birthweight, preterm births and intrauterine growth retardation in relation to maternal smoking. Paediatr Perinat Epidemiol 1997;11(2):140-51.
- Astley SJ, Clarren SK. Diagnosing the full spectrum of fetal alcohol exposed individuals: introducing the 4-digit diagnostic code. Alcohol Alcohol 2000;35(4):400-10.
- Dunty WC, Chen S, Zucker RM, Dehart DB, Sulik K. Selective vulnerability of embryonic cell populations to ethanol-induced apoptosis: implications for alcohol-related birth defects and neurodevelopmental disorder. Alcohol Clin Exp Res 2001;25(10):1523-35.
- Simpson TL, Miller WR. Concomitance between childhood sexual and physical abuse and substance use problems: a review. Clin Psychol Rev 2002;22(1):27-77.
- Bondy SJ, Rehm J, Ashley MJ, Walsh G, Single E, Room R. Low-risk drinking guidelines: the scientific evidence. Can J Public Health 1999;90(4):264-70.
- Astley SJ, Bailey D, Talbot C, Clarren SK. Fetal alcohol syndrome (FAS) primary prevention through FAS diagnosis: I. Identification of high-risk birth mothers through the diagnosis of their children. Alcohol Alcohol 2000;35(5):499-508.
- Chudley A, Conry J, Cook J, Loocke C, Rosales T, LeBlanc N. Fetal alcohol spectrum disoder: Canadian guidelines for diagnosis. CMAJ 2005;172(5 Suppl):S1-21.
- Streissguth AP, Bookstein FL, Barr HM, Sampson PD, O?Malley K, Young JK. Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects. J Dev Behav Pediatr 2004;25(4):228-38.
- Gareri J, Chan D, Klein J, Koren G. Screening for fetal alcohol spectrum disorder. Can Fam Physician 2005;51:33-4.
Motherisk questions are prepared by the Motherisk Team at the Hospital for Sick Children in Toronto, Ont. Dr Tough is an Associate Professor in the Departments of Paediatrics and Community Health Sciences at the University of Calgary in Alberta and is former Director of the Decision Support Research Team in the Calgary Health Region. Dr Clarke is Division Head of Developmental Pediatrics and a Professor in the Department of Paediatrics at the University of Calgary. Dr Clarren is a Clinical Professor in the Division of Developmental Pediatrics at the University of British Columbia in Vancouver.
Published Motherisk Updates are available on the College of Family Physicians of Canada website.